Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Adverse effects of interleukin 2].

A Ravaud1, S Negrier, F Lakdja

  • 1Services de médecine, anesthésie-réanimation, fondation Bergonié, Bordeaux, France.

Bulletin Du Cancer
|November 1, 1991
PubMed
Summary

Interleukin 2 (IL-2) immunotherapy causes significant toxic effects, including systemic, cardiac, and renal issues, with a 1-3% mortality rate. Patient selection and specialized care are crucial for managing IL-2 toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Enrichment of cell cycle pathways in progesterone-treated endometrial organoids of infertile women compared to fertile women.

Journal of assisted reproduction and genetics·2024
Same author

ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Local production of 17β-oestradiol in the endometrium during the implantation window: a pilot study.

Reproduction & fertility·2023
Same author

Uveal melanoma: In the era of new treatments.

Cancer treatment reviews·2023

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Context:

  • Interleukin 2 (IL-2) is a cytokine used in cancer immunotherapy.
  • IL-2 therapy is associated with a spectrum of significant adverse events.
  • Understanding and managing IL-2 toxicity is critical for patient safety.

Purpose:

  • To comprehensively review the toxic effects of Interleukin 2.
  • To outline the range of adverse events associated with IL-2 administration.
  • To emphasize the importance of patient selection and specialized care in mitigating IL-2 toxicity.

Summary:

  • Interleukin 2 (IL-2) administration frequently results in dose-dependent and generally reversible toxicities.
  • Observed side effects span systemic, hemodynamic, cardiac, renal, infectious, cutaneous, hematologic, gastrointestinal, endocrinologic, and metabolic systems.

Related Experiment Videos

  • While treatments for these side effects are established, patient selection and intensive care remain essential, with a 1-3% mortality rate.

    • Impact:

    • Highlights the critical need for careful patient monitoring during IL-2 therapy.
    • Informs clinical practice regarding the management of severe adverse events from IL-2.
    • Underscores the importance of specialized care units for patients receiving IL-2 immunotherapy.